Media
Cessation Therapeutics Announces Food and Drug Administration Authorization for First-in-Human Clinical Trial of Antibody for Prevention of Fentanyl Overdose
CHAPEL HILL, N.C.–(BUSINESS WIRE)–Cessation Therapeutics, Inc., (“Cessation”) a clinical-stage biotechnology company advancing biologics that target substances of abuse, announced today that the U.S. Food and
Tens of Thousands of Americans are Dying Every Year from Fentanyl Overdose It’s time to fight fentanyl like the foe that it is
As a Navy admiral, I helped lead one of the most powerful militaries in the world. Today, our nation is fighting an urgent war right
Cessation Therapeutics’ Anti-Fentanyl Monoclonal Antibody Treatment Shows Promise in Protecting Against Fentanyl-Induced Overdose
Single administration of treatment blocked life-threatening, fentanyl-induced respiratory depression in non-human primates for at least 3 weeks CHAPEL HILL, N.C.–(BUSINESS WIRE)–Cessation Therapeutics (“Cessation”), an early-stage
Cessation Therapeutics Featured in Article “Opioid Vaccines as a Tool to Stem Overdose Deaths”
Cessation Therapeutics, Inc, a preclinical stage biotechnology company focused on developing novel immunotherapeutics and small molecules to treat addiction, was featured in an article in
Cessation Therapeutics’ Anti-Fentanyl Monoclonal Antibody Treatment Shows Promise in Protecting Against Fentanyl-Induced Overdose
CHAPEL HILL, N.C.–(BUSINESS WIRE)–Cessation Therapeutics (“Cessation”), an early-stage biotechnology company focused on the development of novel immunobiologics for preventing and treating fentanyl overdose, today announced
New From Cessation
Email - media
media@cessationtx.com
Most Popular Stories
Cessation Therapeutics Announces Food and Drug Administration Authorization for First-in-Human Clinical Trial of Antibody for Prevention of Fentanyl Overdose
CHAPEL HILL, N.C.–(BUSINESS WIRE)–Cessation Therapeutics, Inc., (“Cessation”) a clinical-stage biotechnology company advancing biologics that target substances of abuse, announced today that the U.S. Food and
Tens of Thousands of Americans are Dying Every Year from Fentanyl Overdose It’s time to fight fentanyl like the foe that it is
As a Navy admiral, I helped lead one of the most powerful militaries in the world. Today, our nation is fighting an urgent war right
Cessation Therapeutics’ Anti-Fentanyl Monoclonal Antibody Treatment Shows Promise in Protecting Against Fentanyl-Induced Overdose
Single administration of treatment blocked life-threatening, fentanyl-induced respiratory depression in non-human primates for at least 3 weeks CHAPEL HILL, N.C.–(BUSINESS WIRE)–Cessation Therapeutics (“Cessation”), an early-stage
Cessation Therapeutics Featured in Article “Opioid Vaccines as a Tool to Stem Overdose Deaths”
Cessation Therapeutics, Inc, a preclinical stage biotechnology company focused on developing novel immunotherapeutics and small molecules to treat addiction, was featured in an article in